H. pylori Ag Rapid Test, Cs – 25 Tests/Kit

H. pylori Ag Rapid Test, Cs – 25 Tests/Kit

Introduction

The H. pylori Ag Rapid Test, Cs – 25 Tests/Kit is a reliable diagnostic tool designed for the rapid detection of Helicobacter pylori antigens in human stool samples. This test plays a crucial role in the diagnosis of gastrointestinal infections associated with H. pylori, enabling timely clinical intervention and improved patient outcomes.

H. pylori infection is one of the most common chronic bacterial infections worldwide and is strongly associated with gastritis, peptic ulcers, and gastric cancer.

What is Helicobacter pylori?

Helicobacter pylori is a Gram-negative, spiral-shaped bacterium that colonizes the human stomach. It survives in the acidic gastric environment by producing urease, which neutralizes stomach acid.

Clinical significance:

  • Chronic gastritis
  • Peptic ulcer disease
  • Gastric adenocarcinoma
  • Mucosa-associated lymphoid tissue (MALT) lymphoma

The World Health Organization has classified H. pylori as a Group 1 carcinogen, emphasizing the importance of early detection and treatment.

Principle of the H. pylori Ag Rapid Test

The H. pylori Ag Rapid Test, Cs – 25 Tests/Kit is based on a lateral flow immunochromatographic assay (LFIA).

Mechanism of action:

  • The test uses specific monoclonal antibodies against H. pylori antigens
  • Stool samples are applied to the test cassette
  • Antigens, if present, bind to labeled antibodies
  • The complex migrates along a membrane and forms visible lines

Result interpretation:

  • Two lines (Control + Test): Positive
  • One line (Control only): Negative
  • No control line: Invalid test

Key Features and Specifications

  • Sample type: Human stool
  • Format: Cassette (Cs)
  • Tests per kit: 25
  • Detection method: Immunochromatographic assay
  • Time to result: 10–15 minutes
  • Sensitivity/Specificity: High diagnostic accuracy
  • Storage conditions: Typically 2–30°C

This kit is optimized for both clinical laboratories and point-of-care testing (POCT) environments.

Test Procedure Workflow

1. Sample Collection

  • Collect a small stool specimen using the provided applicator

2. Sample Preparation

  • Mix the sample with extraction buffer

3. Application

  • Add drops of the prepared sample into the test cassette

4. Incubation

  • Allow migration for 10–15 minutes

5. Result Reading

  • Observe colored lines in the result window

Clinical Applications

The H. pylori Ag Rapid Test, Cs – 25 Tests/Kit is widely used in:

1. Primary Diagnosis

  • Detection of active H. pylori infection
  • Alternative to invasive biopsy methods

2. Post-Treatment Monitoring

  • Confirmation of eradication after antibiotic therapy

3. Gastroenterology Practice

  • Screening patients with dyspepsia or chronic gastric symptoms

Advantages Over Other Diagnostic Methods

Method Invasiveness Time Cost Detection Type
Rapid Antigen Test Non-invasive 10–15 min Low Active infection
Urea Breath Test Non-invasive Moderate Medium Active infection
Endoscopy + Biopsy Invasive Long High Direct observation
Serology Non-invasive Fast Low Past exposure

The rapid antigen test is particularly valuable because it detects current infection, unlike serological tests.

Importance of Rapid Detection

Early detection of Helicobacter pylori is essential for:

  • Preventing ulcer progression
  • Reducing risk of gastric cancer
  • Guiding appropriate antibiotic therapy
  • Limiting transmission

Timely diagnosis improves patient management and reduces long-term complications.

Limitations

  • False negatives may occur with low antigen levels
  • Sample handling affects accuracy
  • Confirmation may be required in ambiguous cases

Conclusion

The H. pylori Ag Rapid Test, Cs – 25 Tests/Kit is a fast, accurate, and non-invasive diagnostic solution for detecting H. pylori infections. Its ease of use and rapid turnaround make it an essential tool in modern clinical diagnostics and point-of-care testing.

Integrating this test into routine screening protocols enhances early diagnosis, treatment monitoring, and overall gastrointestinal health management.